News

Ideas That Generate Results

Emerging countries have outperformed the growth of pharma markets in developed countries. Strong economic growth, rising prevalence of diseases, increasing health awareness and low cost of drugs are among several reasons that have led to such a performance. According to our new research study "Emerging Pharmaceutical Markets Globally", pharmaceutical markets in emerging countries are forecast to grow at a CAGR of around 15% during 2009-2012.

Our report is an outcome of an extensive analysis of pharma market is emerging countries (Brazil, Russia, India, Turkey, Mexico, China and Indonesia). It provides complete information on pharmaceutical markets in these countries. The report identifies that China has the largest pharma market among these countries and it will continue to dominate these markets in near future also. We have found that the highest growth rate will be achieved by the Russian market, followed by China and Brazil.

We believe that economic factors play an important role in the growth of pharma markets, and our report provides a complete analysis on economic factors in these countries that are affecting the pharma market. Besides this, the report also provides information on disease demographics of the countries which will help clients in identifying the potential of the industry. We have found that the market is currently dominated by acute therapies, but this trend is changing now and chronic therapies are also increasing their market share rapidly due to rising prevalence of lifestyle diseases in these countries. The report also explores the opportunities that are emerging in these markets with the development of the industry.

"Emerging Pharmaceutical Markets Globally" also provides crucial information of the key competitors in the market along with their business profile and areas of expertise. This will help the clients in understanding the market in a better way and provides them with an additional edge over their competitors in the market.

For more information visit: http://www.rncos.com/Report/IM081.htm